BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2020 3:06:40 PM | Browse: 1002 | Download: 1998
 |
Received |
|
2020-04-24 09:36 |
|
Peer-Review Started |
|
2020-04-24 09:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-06-13 02:49 |
|
Revised |
|
2020-07-18 12:13 |
|
Second Decision |
|
2020-07-28 10:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-07-30 05:35 |
|
Articles in Press |
|
2020-07-30 05:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-08-10 07:28 |
|
Typeset the Manuscript |
|
2020-08-28 03:08 |
|
Publish the Manuscript Online |
|
2020-08-28 15:06 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Current status of Helicobacter pylori eradication and risk factors for eradication failure
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tian-Lian Yan, Jian-Guo Gao, Jing-Hua Wang, Dan Chen, Chao Lu and Cheng-Fu Xu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
81600447 |
|
| Corresponding Author |
Cheng-Fu Xu, MD, Doctor, Doctor, Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79, Qingchun Road, Hangzhou 310003, Zhejiang Province, China. xiaofu@zju.edu.cn |
| Key Words |
Helicobacter pylori; Eradication; Quadruple therapy; Proton pump inhibitor; Retrospective study; |
| Core Tip |
The Helicobacter pylori eradication rate is decreasing worldwide, and there is a lack of recent data from China. The current study of 14-d quadruple regimens in Eastern China revealed an eradication rate of 76.6%. Amoxicillin-containing regimens had the highest eradication rate in primary therapy, and amoxicillin-plus furazolidone-containing regimens showed superiority in rescue therapy. Age, prior therapy, and use of omeprazole or pantoprazole were independent risk factors of eradication failure. This study can improve choice of antibiotics and proton pump inhibitors and indicates that in clinical practice, attention should be paid to elderly patients and rescue therapy. |
| Publish Date |
2020-08-28 15:06 |
| Citation |
Yan TL, Gao JG, Wang JH, Chen D, Lu C, Xu CF. Current status of Helicobacter pylori eradication and risk factors for eradication failure. World J Gastroenterol 2020; 26(32): 4846-4856 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i32/4846.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i32.4846 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
